Literature DB >> 10403183

Models to study the pathogenesis of thyroid autoimmunity.

A Krogh Rasmussen1, M L Hartoft-Nielsen, U Feldt-Rasmussen.   

Abstract

In vitro and in vivo models to study the pathogenesis of thyroid autoimmunity are reviewed. Animal models with experimentally induced or spontaneously developed autoimmune thyroid disease as well as transplantation models have been used extensively in these studies, but also the use of thyroid cell cultures from both humans and animals has contributed to the present state of knowledge. Cytokines may play a role in the pathogenic mechanism in thyroid autoimmunity. The major in vitro and in vivo effects of for example interleukin-1, tumour necrosis factor and gamma-interferon on differentiated thyroid cell functions are inhibitory. The advantage of using cell cultures has been the possibility of studying an influence on thyrocytes from a single agent individually, such as cytokines, hormones or growth factors. The disadvantage is that an organism is under the influence of a multitude of factors that can only be investigated in vivo in intact organisms. Both types of models have therefore been important in the understanding of thyroid autoimmunity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10403183     DOI: 10.1016/s0300-9084(99)80103-5

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  2 in total

1.  Thyroid hormone autoantibodies in primary Sjögren syndrome and rheumatoid arthritis are more prevalent than in autoimmune thyroid disease, becoming progressively more frequent in these diseases.

Authors:  R M Ruggeri; M Galletti; M G Mandolfino; P Aragona; S Bartolone; G Giorgianni; D Alesci; F Trimarchi; S Benvenga
Journal:  J Endocrinol Invest       Date:  2002-05       Impact factor: 4.256

2.  Thyroid hormone autoantibodies: are they a better marker to detect early thyroid damage in patients with hematologic cancers receiving tyrosine kinase inhibitor or immunoregulatory drug treatments?

Authors:  P Mondello; M Mian; V Pitini; S Cuzzocrea; A Sindoni; M Galletti; M Mandolfino; D Santoro; S Mondello; C Aloisi; G Altavilla; S Benvenga
Journal:  Curr Oncol       Date:  2016-06-09       Impact factor: 3.677

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.